Back to top
Fidelity Advisor Biotechnology Cl A: (MF: FBTAX)
(NASDAQ Mutual Funds) As of Aug 7, 2024 08:00 PM ET
$30.45 USD
-0.60 (-1.93%)
Zacks MF Rank
1-Strong Buy of 5 1
Latest Performance as of Jun 30, 2024
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 9.51 | 37 |
| 3 months | -3.23 | 86 |
| 6 months | 9.51 | 37 |
| 1 Year | 22.28 | 6 |
| 3 Year | 3.11 | 38 |
| 5 Year | 9.75 | 37 |
| 10 Year | 8.44 | 64 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 102.98 |
| Bear Market (10/07 - 2/09) | -26.12 |
| Bull Market (2/09 - 3/21) | 766.47 |
Load Adjusted Returns as of Jun 30, 2024
| 1 Year | 15.63 |
| 5 Year | 8.53 |
| 10 Year | 7.83 |
| Since Inception | 7.16 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2024 | 13.16 | -3.23 | NA | NA |
| 2023 | -4.75 | 4.07 | -4.88 | 17.39 |
| 2022 | -8.31 | -13.97 | 9.19 | 6.88 |
| 2021 | -3.56 | 1.77 | 1.24 | -2.94 |
| 2020 | -11.37 | 30.28 | -0.37 | 14.87 |
| 2019 | 14.19 | -1.70 | -8.41 | 22.28 |
Annual Return
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 9.51 | 10.67 | -7.95 | -3.56 | 32.15 | 25.70 | -3.77 | 25.80 | -23.58 | 11.07 | 34.33 |
| % Total Return Rel to Index | -5.79 | -15.56 | 10.25 | -32.24 | 13.75 | -5.78 | 0.61 | 4.00 | -35.52 | 9.68 | 20.69 |
| % Total Return Rel to Peer | 2.45 | 4.91 | 1.46 | -12.25 | 10.88 | -0.98 | -3.89 | 3.68 | -12.80 | 3.64 | 8.66 |
| % Perf Quintile vs Peer* | 0.00 | 1.00 | 2.00 | 5.00 | 1.00 | 3.00 | 4.00 | 2.00 | 5.00 | 2.00 | 1.00 |
| % Dividends | 0.00 | 0.31 | 0.00 | 0.21 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 1.08 | 0.00 | 0.63 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 0.00 | 0.00 | 0.00 | 5.25 | 2.81 | 1.88 | 0.59 | 0.00 | 0.00 | 1.40 | 0.60 |
| Expense Ratio | 1.00 | 1.00 | 1.00 | 1.00 | 1.02 | 1.03 | 1.06 | 1.04 | 1.04 | 1.04 | 1.08 |
* 1 = Top 20%, 5 = Bottom 20%